The startup develops injectable scaffolds and foams that mimic the extracellular matrix to promote tissue repair and remodeling at the injection site. Their products provide healthcare professionals with effective tools to enhance the body's natural healing processes in various medical applications.

Immunis is a biotechnology company developing IMM01-STEM, a biologic therapy that utilizes natural human immune modulators to enhance muscle regeneration and metabolism. The company is conducting a Phase 1/2a clinical trial to evaluate the therapy's effectiveness in treating age-related muscle atrophy.